Cannabis-Related Securities | Monthly Update | October 2023
October 2023 saw precious little support for cannabis equities (see above), and many CRBs returned to their pre-HHS rescheduling announcement...
October 2023 saw precious little support for cannabis equities (see above), and many CRBs returned to their pre-HHS rescheduling announcement...
The CRB Monitor Securities Research team covers all aspects of the publicly-traded cannabis ecosystem, including the regulatory environment, operational expansion/M&A...
With the hysteria over The announcement that the US Department of Health and Human Services recommended rescheduling cannabis to Schedule...
This month we take a closer look at the near-term health of the largest 20 pure play Tier 1 CRBs,...